secwatch.observer — SEC 8-K summary
======================================

Issuer:     Co-Diagnostics, Inc. (CODX)
CIK:        0001692415
Form:       8-K
Filed at:   2025-10-20T23:59:59+00:00
Accession:  0001493152-25-018591
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 1.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Co-Diagnostics enters $10M ATM equity distribution with Maxim Group, terminates prior Piper Sandler ATM
--------------------------------------------------------------------------------

- New ATM allows sale of up to $10M in common stock through Maxim Group at market prices; 3.0% commission.
- Prior ATM agreement with Piper Sandler and Clear Street terminated effective September 30, 2025.
- Shares sold under existing effective S-3 shelf (333-270628); prospectus supplement filed Oct 20, 2025.
- Company has no obligation to sell any shares; offering may be terminated at any time.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1692415/000149315225018591/0001493152-25-018591-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1692415/000149315225018591/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-018591

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer